SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 336.3% in June

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a large growth in short interest in June. As of June 15th, there was short interest totalling 69,800 shares, a growth of 336.3% from the May 31st total of 16,000 shares. Based on an average daily volume of 361,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 2.9% of the company’s shares are short sold.

SciSparc Trading Down 6.0 %

NASDAQ SPRC traded down $0.05 during trading on Friday, reaching $0.80. 72,916 shares of the company’s stock were exchanged, compared to its average volume of 727,676. SciSparc has a fifty-two week low of $0.80 and a fifty-two week high of $15.86. The company’s fifty day simple moving average is $1.10 and its 200-day simple moving average is $2.72.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.